Drugs / melanoma GVAX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01435499 | Sep 2011 → Jan 2013 | melanoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | melanoma GVAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01435499 ↗ |
| Modality | Vaccine | “Melanoma GVAX, a lethally irradiated granulocyte-macrophage colony stimulating factor (GM-CSF)-secreting allogeneic whole-cell melanoma vaccine” PMID 26143264 ↗ Jul 2015 |